Libros importados con hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada primary progressive multiple sclerosis (in English)
Type
Physical Book
Illustrated by
Publisher
Year
2012
Language
Inglés
Pages
128
Format
Paperback
Dimensions
23.4 x 15.6 x 0.8 cm
Weight
0.20 kg.
ISBN
8847022363
ISBN13
9788847022362

primary progressive multiple sclerosis (in English)

M. Filippi (Illustrated by) · G. Comi (Illustrated by) · Springer · Paperback

primary progressive multiple sclerosis (in English) - Filippi, M. ; Comi, G.

Physical Book

$ 52.09

$ 54.99

You save: $ 2.90

5% discount
  • Condition: New
It will be shipped from our warehouse between Friday, June 28 and Monday, July 01.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "primary progressive multiple sclerosis (in English)"

"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin- ical trials have excluded PPMS patients on two counts. Clinical worsening devel- ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the -interferons and glatiramer acetate, preliminary, uncontrolled clinical experi- ence suggests that the results may not be dramatic.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews